Industry, innovation and social values
- PMID: 15726997
- PMCID: PMC7089058
- DOI: 10.1007/s11948-005-0053-9
Industry, innovation and social values
Abstract
Remaining important tasks in finding and developing new drugs and vaccines for HIV/AIDS, malaria, cancer and other diseases require continued industry research and development. Industry's research and development pipeline has produced drugs that have saved AIDS victims previously facing certain death, but still no cure nor vaccine is yet available. Experience with the process of research and development indicates that it requires more than a decade of development to produce a new drug with costs in the hundreds of millions of dollars. Intellectual property protection is critically important in assuring that drug development continues. Partnerships between industry and the public sector have increased access to new therapies in developing countries and promise to enhance access to both patented and generic medicines in the future.
Similar articles
-
Raising the Barriers to Access to Medicines in the Developing World - The Relentless Push for Data Exclusivity.Dev World Bioeth. 2017 Apr;17(1):11-21. doi: 10.1111/dewb.12105. Epub 2016 Jan 27. Dev World Bioeth. 2017. PMID: 26818105 Free PMC article.
-
Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.PLoS Med. 2007 Nov 13;4(11):e305. doi: 10.1371/journal.pmed.0040305. PLoS Med. 2007. PMID: 18001145 Free PMC article.
-
University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.Am J Law Med. 2009;35(2-3):253-79. doi: 10.1177/009885880903500202. Am J Law Med. 2009. PMID: 19697749
-
The pharmaceutical industry as a medicines provider.Lancet. 2002 Nov 16;360(9345):1590-5. doi: 10.1016/S0140-6736(02)11527-3. Lancet. 2002. PMID: 12443614 Review.
-
Pharmaceutical industry's corporate social responsibility towards HIV/AIDS.J Postgrad Med. 2006 Jul-Sep;52(3):194-6. J Postgrad Med. 2006. PMID: 16855320 Review.
References
-
- Commission on Macroeconomics and Health, Macroeconomics and health: Investing in health for economic development. CMH/WHO 2001, pp- 21–29.
-
- Brower J., Chalk P. (2003) The global threat of new and re-emerging infectious diseases: reconciling US national security and public health policy. Rand Science and Technology 2003.
-
- Joint United Nations Programme on HIV/AIDS (UNAIDS), AIDS Epidemic Update: December 2003. UNAIDS 2003. - PubMed
-
- Reichert J.M., Milne Ch. P. (2000) Public good and private goods: the role of industry, academia, and government in drug discovery and development. Tufts Centre for the Study of Drug Development, 2000.
-
- Henderson R., Cockburn I. (1993) Measuring competence? Exploring Firm Effects in Pharmaeutical Research. Strategic Management Journal, No. 15.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical